| NeurosCIeNCe | artiCLe References


1. Bellinger FP, Bellinger MT, Seale LA et al. Glutathione Peroxidase 4 is associated with Neuromelanin in Substantia Nigra and Dystrophic Axons in Putamen of Parkinson’s brain. Mol Neurodegener 2011; 6(1): 8


2. Halliday GM, Ophof A, Broe M et al. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson’s disease. Brain 2005; 128(Pt 11): 2654–64


3. Threlfell S, Cragg SJ. Dopamine signaling in dorsal versus ventral striatum: the dynamic role of cholinergic interneurons. Front Syst Neurosci 2011; 5: 11


4. Sookoian S, Gianotti TF, Burgueño A, Pirola CJ. Gene-gene interaction between serotonin transporter (SLC6A4) and CLOCK modulates the risk of metabolic syndrome in rotating shiftworkers. Chronobiol Int 2010; 27(6): 1202–18


5. Joyner MJ, Casey DP. The catecholamines strike back. What NO does not do. Circ J 2009; 73(10): 1783–92


6. Suschek CV, Opländer C, van Faassen EE. Non-enzymatic NO production in human skin: effect of UVA on cutaneous NO stores. Nitric Oxide 2010; 22(2): 120–135


7. Lundberg JO, Weitzberg E, Gladwin MT. The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics. Nat Rev Drug Discov 2008; 7(2): 156–67


8. West MB, Hill BG, Xuan YT, Bhatnagar A. Protein glutathiolation by nitric oxide: an intracellular mechanism regulating redox protein modification. FASEB J 2006; 20(10): 1715–7


9. Diehl C, Lipozencić J, Ledić-Drvar D. The basis of topical superoxide dismutase antipruritic activity. Acta Dermatovenerol Croat 2009; 17(1): 25–39


10.Wek RC, Jiang HY, Anthony TG. Coping


with stress: eIF2 kinases and translational control. Biochem Soc Trans 2006; 34(Pt 1): 7–11


11. Tong L, Heim RA, Wu S. Nitric oxide: A regulator of eukaryotic initiation factor 2 kinases. Free Radic Biol Med 2011; [epub ahead of print]


12. Cleeter MW, Cooper JM, Darley-Usmar VM,


Moncada S, Schapira AH. Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide. Implications for neurodegenerative diseases. FEBS Lett 1994; 345(1): 50–4


13. Chang EJ, Kundu JK, Liu L. Ultraviolet B radiation activates NF-κB and induces iNOS expression in HR-1 hairless mouse skin: Role of IκB kinase-β. Mol Carcinog 2011; 50(4): 310–7


14. Royal CR, Ma H, Walker R, White RE. Estrogen signaling in microvascular arteries: Parturition reduces vasodilation by reducing 17β-estradiol and nNOS. Steroids 2011; [Epub ahead of print]


15. Fuziwara S, Suzuki A, Inoue K, Denda M.


Dopamine D2-like receptor agonists accelerate barrier repair and inhibit the epidermal hyperplasia induced by barrier disruption. J Invest Dermatol 2005; 125(4): 783–9


16. Moshkov DA, Pavlik LL, Shubina VS,


Parnyshkova EIu, Mikheeva IB. Cytoskeletal regulation of the cellular function by dopamine. Biofizika 2010; 55(5): 850–6


17. Habecker BA, Klein MG, Sundgren NC, Li W,


Woodward WR. Developmental regulation of neurotransmitter phenotype through tetrahydrobiopterin. J Neurosci 2002; 22(21): 9445–52


18. Williams A, Ballenger J, Levine R, Lovenberg W, Calne D. ging and CSF hydroxylase cofactor. Neurology. 1980 Nov; 30(11): 1244–6


19. Slominski A, Wortsman J, Pisarchik A et al.


Cutaneous expression of corticotropin releasing hormone (CRH), urocortin, and CRH receptors. FASEB J 2001; 15(10): 1678–93


20.Reiter RJ, Tan DX, Manchester LC, El-Sawi


MR. Melatonin reduces oxidant damage and promotes mitochondrial respiration: implications for aging. Ann N Y Acad Sci 2002; 959: 238–50


21. Fischer TW, Greif C, Fluhr JW, Wigger- Alberti W, Elsner P. Percutaneous penetration of topically applied melatonin in a cream and an alcoholic solution. Skin Pharmacol Physiol 2004; 17(4): 190–4


22. Elwary SM, Chavan B, Schallreuter KU. The


vesicular acetylcholine transporter is present in melanocytes and keratinocytes in the human epidermis. J Invest Dermatol 2006; 126(8): 1879–84


23. Jacobi J, Jang JJ, Sundram U, Dayoub H, Fajardo LF, Cooke JP. Nicotine accelerates angiogenesis and wound healing in genetically diabetic mice. Am J Pathol 2002; 161(1): 97–104


24. Sales ME. Muscarinic receptors as targets


for anti-inflammatory therapy. Curr Opin Investig Drugs 2010; 11(11): 1239–45


25. Ketel IJ, Stehouwer CD, Serné EH et al.


Microvascular function has no menstrual- cycle-dependent variation in healthy ovulatory women. Microcirculation 2009; 16(8): 714–24


26.Camporez JP, Akamine EH, Davel AP et al. Dehydroepiandrosterone protects against oxidative stress-induced endothelial dysfunction in ovariectomized rats. J Physiol 2011; 589(Pt 10): 2585–96


27. Horikawa T, Fukunaga A, Nishigori C. New


concepts of hive formation in cholinergic urticaria. Curr Allergy Asthma Rep 2009; 9(4): 273–9


28. Wollina U. Botulinum Toxin: Non-cosmetic Indications and Possible Mechanisms of Action. J Cutan Aesthet Surg 2008; 1(1): 3–6


29.Gazerani P, Pedersen NS, Drewes AM,


Arendt-Nielsen L. Botulinum toxin type A reduces histamine-induced itch and vasomotor responses in human skin. Br J Dermatol 2009; 161(4): 737–45


30.Low PA, Dyck PJ. Splanchnic preganglionic


neurons in man: II. Morphometry of myelinated fibers of T7 ventral spinal root. Acta Neuropathol 1977; 40(3): 219–25


31. Shibasaki M, Davis SL, Cui J, Low DA, Keller DM, Crandall CG. Botulinum toxin abolishes sweating via impaired sweat gland responsiveness to exogenous acetylcholine. Br J Dermatol; 161(4): 757–61


32. Duthey B, Hübner A, Diehl S, Boehncke S,


Pfeffer J Boehncke WH. Anti-inflammatory effects of the GABA(B) receptor agonist baclofen in allergic contact dermatitis. Exp Dermatol 2010; 19(7): 661–6


33. Denda M, Inoue K, Inomata S, Denda S. gamma-Aminobutyric acid (A) receptor agonists accelerate cutaneous barrier recovery and prevent epidermal hyperplasia induced by barrier disruption. J Invest Dermatol 2002; 119(5): 1041–7


34.Nigam R, El-Nour H, Amatya B, Nordlind K.


GABA and GABA(A) receptor expression on immune cells in psoriasis: a pathophysiological role. Arch Dermatol Res 2010; 302(7): 507–15


35. Romana-Souza B, Porto LC, Monte-Alto-


Costa A. Cutaneous wound healing of chronically stressed mice is improved through catecholamines blockade. Exp Dermatol 2010; 19(9): 821–9


36.Pearson J, Low DA, Stöhr E et al.


Hemodynamic responses to heat stress in the resting and exercising human leg: insight into the effect of temperature on skeletal muscle blood flow. Am J Physiol Regul Integr Comp Physiol 2011; 300(3): R663–73


37. Huang N, Ashrafpour H, Levine RH et al.


Vasorelaxation Effect and Mechanism of Action of Vascular Endothelial Growth Factor-165 in Isolated Perfused Human Skin Flaps. J Surg Res 2010; [epub ahead of print]


38. Lundberg JM, Pernow J, Tatemoto K, Dahlöf C. Pre- and postjunctional effects of NPY on sympathetic control of rat femoral artery. Acta Physiol Scand 1985; 123(4): 511–3


39. Hodges GJ, Jackson DN, Mattar L, Johnson


JM, Shoemaker JK. Neuropeptide Y and neurovascular control in skeletal muscle and skin. Am J Physiol Regul Integr Comp Physiol 2009; 297(3): R546–55


40.Sreevidya CS, Khaskhely NM, Fukunaga A,


Khaskina P, Ullrich SE. Inhibition of photocarcinogenesis by platelet-activating factor or serotonin receptor antagonists. Cancer Res 2008; 68(10): 3978–84


41. Jørgensen KM, Felberg HS, Berge RK, Laegreid A, Johansen B. Platelet activating factor stimulates arachidonic acid release in differentiated keratinocytes via arachidonyl non-selective phospholipase A2. Arch Dermatol Res 2010; 302(3): 221–7


42.Sibille E, Su J, Leman S et al. Lack of


serotonin1B receptor expression leads to age-related motor dysfunction, early onset of brain molecular aging and reduced longevity. Mol Psychiatry 2007; 12(11): 1042–56, 975


43.Lonne-Rahm SB, Rickberg H, El-Nour H,


Mårin P, Azmitia EC, Nordlind K. Neuroimmune mechanisms in patients with atopic dermatitis during chronic stress. J Eur Acad Dermatol Venereol 2008; 22(1): 11–8


44.Oxenkrug G. Antioxidant effects of N-acetylserotonin: possible mechanisms and clinical implications. Ann N Y Acad Sci 2005; 1053: 334–47


45. [No authors listed] Understanding the


stress response. Chronic activation of this survival mechanism impairs health. Harv Ment Health Lett 2011; 27(9): 4–5


46.Yang FZ, Wu Y, Zhang WG, Cai YY, Shi SX.


[Influence of estradiol on tryptophan hydroxylase and 5-hydroxytryptamine content in raphe nuclei of rats under forced swimming stress]. Zhonghua Yi Xue Za Zhi 2010; 90(27): 1929–32


47. Novella S, Dantas AP, Segarra G et al.


Gathering of aging and estrogen withdrawal in vascular dysfunction of senescent accelerated mice. Exp Gerontol 2010; 45(11): 868–74


48.Plaschke K, Kopitz J, Mattern J, Martin E,


Teschendorf P. Increased cortisol levels and anticholinergic activity in cognitively unimpaired patients. J Neuropsychiatry Clin Neurosci 2010; 22(4): 433–41


49.Yigiter M, Albayrak Y, Polat B, Suleyman B,


Salman AB, Suleyman H. Influence of adrenal hormones in the occurrence and prevention of stress ulcers. J Pediatr Surg 2010; 45(11): 2154–9


50.El-Alfy M, Deloche C, Azzi L et al. Skin


responses to topical dehydroepiandrosterone: implications in antiageing treatment? Br J Dermatol 2010; 163(5): 968–76


51. Makrantonaki E, Schönknecht P, Hossini


AM et al. Skin and brain age together: The role of hormones in the ageing process. Exp Gerontol 2010; 45(10): 801–13


52. de Bruin C, Feelders RA, Waaijers AM et al.


Differential regulation of human dopamine D2 and somatostatin receptor subtype expression by glucocorticoids in vitro. J Mol Endocrinol 2009; 42(1): 47–56


53. Brandes LJ. Hormetic effects of hormones,


antihormones, and antidepressants on cancer cell growth in culture: in vivo correlates. Crit Rev Toxicol 2005; 35(6): 587–92


Summary of the links between hormones and neurotransmitters Neuroransmitter Increased by


Acetylcholine Estradiol, pregnenolone, GABA Serotonin Dopamine Nitric oxide


testosterone, oxytocin, DHEA Progesterone


Estradiol, pregnenolone, short cortisol action, progesterone


DHEA, cortisol, thyroid hormones, Melatonin, progesterone estradiol


Testosterone, estradiol Noradrenaline DHEA, cortisol Cortisol Progesterone DHEA=dehydroepiandrosterone; GABA=gamma-aminobutyric acid prime-journal.com | July 2011 ❚


Decreased by Cortisol


DHEA, pregnenolone, cortisol Long cortisol action


59


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84